Cargando…

Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells

BACKGROUND: Transforming growth factor-β (TGF-β) plays a paradoxical role in cancer: it suppresses proliferation at early stages but promotes metastasis at late stages. This cytokine is upregulated in cholangiocarcinoma and is implicated in cholangiocarcinoma invasion and metastasis. Here we investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sritananuwat, Phaijit, Sueangoen, Natthaporn, Thummarati, Parichut, Islam, Kittiya, Suthiphongchai, Tuangporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615482/ https://www.ncbi.nlm.nih.gov/pubmed/28959141 http://dx.doi.org/10.1186/s12935-017-0454-2

Ejemplares similares

Role of laminin and cognate receptors in cholangiocarcinoma cell migration
por: Islam, Kittiya, et al.
Publicado: (2021)

KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
por: Gao, Zheng, et al.
Publicado: (2022)

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness
por: Yuan, Hui, et al.
Publicado: (2020)

Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients
por: Puetkasichonpasutha, Janpen, et al.
Publicado: (2020)

Effect of Co-culturing Fibroblasts in Human Skeletal Muscle Cell Sheet on Angiogenic Cytokine Balance and Angiogenesis
por: Thummarati, Parichut, et al.
Publicado: (2020)

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021)

ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis
por: Li, Fengwei, et al.
Publicado: (2021)

Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
por: Deng, Min, et al.
Publicado: (2021)

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2022)

PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties
por: Wu, Tsung-Hsien, et al.
Publicado: (2014)

BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways
por: Chen, Xu-Xiao, et al.
Publicado: (2018)

TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
por: Chen, Yijie, et al.
Publicado: (2015)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2023)

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
por: Wang, Da, et al.
Publicado: (2021)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network
por: Kang, Zhichen, et al.
Publicado: (2020)

The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression
por: Mancarella, Serena, et al.
Publicado: (2022)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
por: Jeong, Seorin, et al.
Publicado: (2017)

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
por: Sueangoen, Natthaporn, et al.
Publicado: (2020)

Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma
por: Zhang, Zhen, et al.
Publicado: (2017)

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas
por: Zong, Meijuan, et al.
Publicado: (2013)

Gene expression profiling of the tumor microenvironment in human intrahepatic cholangiocarcinoma
por: Sulpice, Laurent, et al.
Publicado: (2016)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma
por: Buettner, Stefan, et al.
Publicado: (2019)

Intrahepatic cholangiocarcinoma with gastric infiltration misdiagnosed as gastric submucosal tumor
por: Ito, Shunichi, et al.
Publicado: (2020)

Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer
por: Li, Wen, et al.
Publicado: (2021)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

Recent Advances in Cell Sheet Engineering: From Fabrication to Clinical Translation
por: Thummarati, Parichut, et al.
Publicado: (2023)

SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma
por: Yang, Hui, et al.
Publicado: (2022)

Downregulation of tumor‐derived exosomal miR-34c induces cancer‐associated fibroblast activation to promote cholangiocarcinoma progress
por: Qin, Xinglei, et al.
Publicado: (2021)

Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
por: Chen, Hua-Dong, et al.
Publicado: (2020)

Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
por: Kosaka, Hisashi, et al.
Publicado: (2021)

Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma
por: Zhao, Hua, et al.
Publicado: (2022)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_il9q8clgi0a9p3ngr9nrvo6jfc